Related Experiment Video
Updated: Jun 20, 2026

Stress-Enhanced Fear Learning, a Robust Rodent Model of Post-Traumatic Stress Disorder
Published on: October 13, 2018
Sterol carrier protein 2 loss reduces anxiety and enhances fear extinction
Elizabeth Sabens Liedhegner1, Kara L Stuhr1, Elizabeth M Doncheck1
1Department of Pharmacology and Toxicology and Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI, 53226, United States of America.
Abstract:
Brain endocannabinoid (eCB) signaling, which includes CB1 cannabinoid receptors (CB1R) and the eCBs N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG), modulates behavioral responses to stress and fear extinction. Sterol carrier protein 2 (SCP-2) is an intracellular lipid binding protein expressed in brain that binds AEA and 2-AG at nanomolar concentrations and facilitates their cellular accumulation. SCP-2 mRNA is present in mouse limbic brain regions and is increased in the prefrontal cortex (PFC) and amygdalar complex in mice with impaired (129S1/Sv1mJ) fear extinction compared to mice with normal (C57BL/6J) fear extinction. In this study, we utilized mice with deletion of the gene for SCP-2 and an overlapping gene, SCP-X (SCP-2/X-/-), to examine the hypothesis that SCP-2 regulates behaviors associated with anxiety and fear. Compared to WT mice, SCP-2/X-/- mice exhibit enhanced fear extinction and reduced anxiety-driven behaviors in the elevated plus maze. These differences are abrogated by treatment with a CB1R antagonist and not recapitulated in mice with selective deletion of SCP-X. While baseline brain tissue concentrations of AEA and 2-AG are not different between WT and SCP-2/X-/- mice, amygdalar and PFC 2-AG concentrations are significantly higher in SCP-2/X-/- mice 24 h following foot shock. There are no differences between WT and SCP-2/X-/- mice in rectal temperature; or in tail flick and catalepsy assays. These findings support the hypothesis that as yet unproven functions of the lipid carrier protein SCP-2 regulate behaviors associated with fear memory and anxiety and suggest that pharmacological inhibitors of SCP-2 could reduce acute anxiety and enhance fear extinction.
Related Concept Videos
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Preparedness and Phobias
Desensitization and Tachyphylaxis
Several...

